Sandostatin LAR 30mg Injection
Marketer
Novartis India Ltd
Salt Composition
Octreotide acetate (30mg)
Overview Sandostatin LAR 30mg Injection
Octreotide acetate 30mg injection (brand name Sandostatin LAR) treats acromegaly, carcinoid tumors, and gastrointestinal bleeding from esophageal varices. It also helps prevent post-pancreatic surgery complications. Administration is exclusively by a medical professional; self-injection is strictly prohibited. Dosage and frequency are determined by your physician. Consistent use is crucial for optimal therapeutic effect. Discontinuation should only occur under medical supervision. Common side effects include diarrhea, abdominal discomfort, nausea, constipation, gas, and headache. Report persistent or worsening side effects to your doctor. Prior to treatment, disclose any liver conditions and a complete list of all medications you are currently using.
Uses of Sandostatin LAR 30mg Injection
Overgrowth of the extremities, carcinoid cancers, and bleeding esophageal varices.
Major Benefits of Sandostatin LAR 30mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Sandostatin LAR 30mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Sandostatin LAR 30mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Sandostatin LAR 30mg Injection works:
Octreotide acetate 30mg injection, mirroring the natural hormone somatostatin, suppresses the activity of various hormones, including growth hormone. This action also reduces esophageal bleeding by causing vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Sandostatin LAR 30mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Octreotide long-acting release (LAR) 30mg injection is typically deemed safe for use in pregnancy. Preclinical trials using animals revealed minimal or absent negative consequences for fetal development; nevertheless, clinical data in pregnant women are scarce.
Breast feedingSAFE IF PRESCRIBED
Octreotide long-acting release 30mg injection is likely compatible with breastfeeding. Available human data indicates minimal infant risk.
DrivingSAFE
Driving ability is typically unaffected by Sandostatin LAR 30mg Injection.
KidneySAFE IF PRESCRIBED
Octreotide depot 30mg injection poses no safety concerns for patients with renal impairment; dose modification is unnecessary.
LiverCAUTION
Octreotide depot 30mg injection requires careful administration in individuals with hepatic impairment. Dosage modification of octreotide depot 30mg injection might be necessary. Physician consultation is advised.
What if you forget to take Sandostatin LAR 30mg Injection :
Should you forget a Sandostatin LAR 30mg Injection, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Sandostatin LAR 30mg Injection
| Label | Value |
|---|---|
| Chemical Category | Somatostatin analogs |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | Somatostatin receptor ligands |
3,018 People bought this recently